Life Science Business News

08 May 2003 - New deal to improve process in vaccines manufacture

Vivalis and Aventis sign licence agreement for process improvement in manufacturing vaccines Focus on "Large-scale production for HIV and cancer..  More >>

01 May 2003 - French biotech discovers Dutch takeover target

Hybrigenics acquires Semaia in bid to develop novel anti-cancer drugs Merged companies will "leverage proprietary tools to identify and validate oncology..  More >>

14 April 2003 - ML will dispose of Icodextrin manufacturing business to Baxter

Shareholders of ML Laboratories plc have approved the disposal of their company’s Icodextrin manufacturing business to Baxter Healthcare Limited. The..  More >>

28 March 2003 - Flamel's CR technology to pump up GSK's pipeline

GlaxoSmithKline and Flamel Technologies reveal $45m licensing deal to develop new controlled release formulation GlaxoSmithKline, London UK and..  More >>

24 March 2003 - Baxter to acquire ML Labs' Icodextrin manufacturing business

ML Laboratories plc has come to an agreement with Baxter Healthcare Limited that will see ML disposing of its Liverpool based Icodextrin manufacturing business..  More >>

04 February 2003 - Lonza Biologics and Alexion Pharmaceuticals sign commercial biomanufacturing agreement

Alexion Pharmaceuticals, Inc. reveals it has concluded a large-scale product supply agreement with Lonza Biologics for the long term commercial manufacture of..  More >>

10 December 2002 - Galen acquires Sarafem

Galen acquires rights to Sarafem Galen, the biopharmaceutical company based in Ulster with offices in New Jersey has acquired the rights to market..  More >>

09 December 2002 - Pharmacia approves of merger with Pfizer

Pharmacia Corp shareholders at a special meeting approved its proposed merger with Pfizer Inc. About 71% of outstanding shares, and 99% of the total votes..  More >>

09 December 2002 - Pfizer Shareholders approve Pharmacia purchase

Issue of new shares approved to fund purchase while Pharmacia shareholders meet to decide on the bid Pfizer’s shareholders approved the purchase of Pharmacia..  More >>

04 December 2002 - Evotec OAI in collaboration with Prolysis for antibiotics

Biology and chemistry discovery and development agreement ’worth €5 million’ Hamburg, Germany based Evotec OAI AG with an office in Oxford, UK and..  More >>

04 December 2002 - Giliad to acquire Triangle

Gilead Sciences deal to Acquire Triangle Pharmaceuticals worth $464 million Plan involves a two-step acquisition whereby Triangle will become a wholly..  More >>

04 December 2002 - Syngenta and Diversa in biopharma R&D deal

Syngenta and Diversa form R & D alliance Discovery activities in genomics combine for new plant science applications in selected antibody generation and..  More >>